Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data published in Open Forum Infectious Diseases shows earlier use of comprehensive ...
According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...
Building 2 at Knight Campus, a $330 million project, funded by a second $500 million gift from Phil and Penny Knight and $10 ...
Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the ...
Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback